Overview

Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment

Status:
Recruiting
Trial end date:
2022-03-23
Target enrollment:
Participant gender:
Summary
In this case, series, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the PACU in ambulatory surgery patients taking Suboxone.
Phase:
Phase 4
Details
Lead Sponsor:
Montefiore Medical Center
Treatments:
Dsuvia